GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acro Biomedical Co Ltd (ROCO:6748) » Definitions » Debt-to-Asset

Acro Biomedical Co (ROCO:6748) Debt-to-Asset : 0.02 (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acro Biomedical Co Debt-to-Asset?

Acro Biomedical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$5.26 Mil. Acro Biomedical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was NT$10.59 Mil. Acro Biomedical Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was NT$655.33 Mil. Acro Biomedical Co's debt to asset for the quarter that ended in Dec. 2024 was 0.02.


Acro Biomedical Co Debt-to-Asset Historical Data

The historical data trend for Acro Biomedical Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Debt-to-Asset Chart

Acro Biomedical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Asset
Get a 7-Day Free Trial 0.08 0.09 0.03 0.03 0.02

Acro Biomedical Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.06 0.03 0.03 0.02

Competitive Comparison of Acro Biomedical Co's Debt-to-Asset

For the Biotechnology subindustry, Acro Biomedical Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acro Biomedical Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acro Biomedical Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Acro Biomedical Co's Debt-to-Asset falls into.


;
;

Acro Biomedical Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Acro Biomedical Co's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(5.256 + 10.593) / 655.326
=0.02

Acro Biomedical Co's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(5.256 + 10.593) / 655.326
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acro Biomedical Co  (ROCO:6748) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Acro Biomedical Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Acro Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
3rd Floor, No. 57, Luke 2nd Road, Luzhu District, Kaohsiung, TWN
Acro Biomedical Co Ltd is a company whose technical team integrates the Research and development capabilities of Taiwan's major scientific research units and medical centers to jointly develop equipment for repairing organs and tissues in various parts of the human body. It mainly focuses on orthopedics, dentistry, cardiovascular specialists, ophthalmology, surgery, wound care, Medical equipment used in sports injuries and other specialties.

Acro Biomedical Co Headlines

No Headlines